Chronic Low Back Pain Clinical Trial
Official title:
Visceral Manipulation in Patients With Chronic Low Back Pain: Randomized Controlled Trial
Non-specific chronic low back pain is a common multifactorial condition common to the world population. It is defined as a pain and discomfort located below the ribs and above the gluteal folds that may or may not have referred pain in the leg for more than 12 weeks. Visceral manipulation is a manual therapy technique that aims to normalize mechanical, vascular and neurological dysfunctions of the viscera with the objective of improving its functioning. Visceral dysfunction may potentially activate or exacerbate the symptoms of low back pain in the presence of compromised movements between the internal organs and its connective tissues. There are two ways in which a change in visceral mobility could interfere with low back pain, referred visceral pain and central hypersensitivity. The first occurs due to neural convergence, since there is no spinocortical tract that only sends visceral or somatic afferences, its afferences are crossed in the dorsal horn of the spinal cord. The second is that the prolonged and continuous activation of nociceptors, due to the alteration in the mobility of the gastrointestinal and urinary system, can generate central hypersensitivity. Therefore, the investigators hypothesized that through the visceral manipulation the fascial adherences would lyse and the visceral spasms would demise, reducing the peripheral input, thus, lessening pain in the low back.
Ethical aspects: All volunteers will be informed about the experimental procedures that will
be submitted, as well as the fact that these do not affect the participant's health. The
participants will also be clarified as to the secrecy of the information collected during the
study performance, protecting the identities of the participants. After agreeing to
participate in the research, each volunteer will sign the Informed Consent Term, according to
resolution 196/96 and update in resolution 466 in 2012 of the National Health Council.
Risks:The interventions offer no harm to the participant's health. There is the possibility
of the participant feeling pain and / or tickling during abdominal palpation. If these
sensations occur, the procedure will be stopped and tried again. If sensations persist and
the participant can not support them the session will be rescheduled or the participant will
be disconnected from the study as there is no other way to carry out the proposed therapy.
Benefits:There may be no direct or immediate benefits, however, it is expected that the
proposed treatment will improve lumbar pain.
This study does not offer any type of health insurance, and also, it is the responsibility of
the participant to get around and bear the costs of transportation to the place of collection
of data.
Confidentiality and privacy of research participants will be guaranteed during all phases of
the research. At any time the participant can withdraw consent to participate in the research
without any kind of penalty.
The research team is committed to making the search results public, whether favorable or not.
It is worth noting that the placebo intervention procedures will always be performed in
association with an active treatment, which makes its use of less impact to the patient. In
addition, all patients will be informed of the use of this procedure prior to the initiation
of the survey.
Criteria for suspending research: This research will be suspended in the event of
researchers' deaths, closure of the research site or termination of the Term of Science of
the Partner Condition and / or no volunteer to participate in the research.
Financing This study will be funded by the researchers themselves.
Source of Patients: Patients with chronic low back pain will be referred for screening from
online surveys, third party indications, and from patients on the waiting list of the Heath
Center of the University of Sorocaba. The screening, assessment and evaluation will be
performed at the Health Nucleus and in the Integrated Human Movement Laboratory of the
University of Sorocaba.
Procedure: The researchers will inform the study objectives and procedures to all patients.
If the participants agree to participate, the participants will sign an informed consent
form. After that, a therapist will assess them for demographic data and baseline measures,
such as pain level (0-10 Numerical Pain Rating Scale), disability associated with low back
pain (Roland-Morris Disability Questionnaire), and function (0-10 Patient-Specific Functional
Scale)
Random Allocation: One of the researchers will create a randomization code with 1:1
allocation radio using Excel for Windows software. The codes will be the words "E" for
experimental or "P" for placebo, then ithe codes will be sealed on opaque envelopes, thus
ensuring the concealed allocation of participants to groups. At the first encounter with the
treating therapist, patients will choose one of the envelopes on a table and give it to the
therapist. The therapist will open it in a different room from the patient and allocate the
patient to the group according to the randomization schedule.
Interventions: The volunteers will be allocated in the Experimental group or the Control
Group. In the Experimental, the participants will receive the Standard care physiotherapy
plus Active visceral manipulation, while the Control will receive Standard care physiotherapy
and Placebo visceral manipulation. The standard care physiotherapy lasts 40 minutes and the
visceral mobilisation takes around 10 minutes.
Blinding: The assessor and the therapist will be blind to each others work. Therefore the
assessor will not have knowledge of the treatment allocation and will perform three
assessments, the pre assessment, immediately after the last treatment and 1 week after the
treatment. Similarly, the therapist will not know the pre- and post-assessment intervention.
In addition, there will be only one assessor and one therapist for the research to decrease
bias. To test the blinding, after the last treatment session, the assessor will write on the
patient's assessment chart which type of intervention (active or placebo) he thought the
participant had received. These codes will be later compared with the randomization codes.
Statistical methods: Statistical analysis will be used SPSS (Statistical Package for Social
Sciences) v.19.0. Initially the Kolmogorov-Smirnov test will be performed. If the data are
normal, parametric tests will be applied, if the distribution is non-normal, non-parametric
tests will be used. It will be calculated from the effect size, by means of the difference
between the means of the pre-intervention evaluation and the post-intervention evaluation. In
all analyzes, a critical level of 5% (p <0.05) will be set.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |